Researchers Reveal Promising Treatment Target for Resistant Brain Cancer
May 18, 2024
May 18, 2024
ROANOKE, Virginia, May 18 (TNSres) -- The Fralin Biomedical Research Institute at Virginia Tech issued the following news:
By John Pastor
For many patients with a deadly type of brain cancer called glioblastoma, chemotherapy resistance is a big problem.
Current standard treatments, including surgery, radiation, and chemotherapy using the drug temozolomide, have limited effectiveness and have not significantly changed in the past five decades. Although temoz . . .
By John Pastor
For many patients with a deadly type of brain cancer called glioblastoma, chemotherapy resistance is a big problem.
Current standard treatments, including surgery, radiation, and chemotherapy using the drug temozolomide, have limited effectiveness and have not significantly changed in the past five decades. Although temoz . . .